How I Use New Targeted Agents to Improve Outcomes for My Patients With AML

Discussion - Here are my thoughts on how best to apply the recently approved targeted agents gemtuzumab ozogamicin, midostaurin, and enasidenib to improve outcomes for your patients with acute myeloid leukemia.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research